Pieris Pharmaceuticals Inc logo

Pieris Pharmaceuticals Inc

$ 1.00 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
2.08
Market Cap:
$ 74.41M
Enterprise V:
$ 16.80M
Volume:
83.40K
Avg Vol (2M):
264.19K
Also Trade In:
Volume:
83.40K
Market Cap $:
74.41M
PE Ratio:
At Loss
Avg Vol (2-Month):
264.19K
Enterprise Value $:
16.80M
PB Ratio:
2.08
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 5.72
Equity-to-Asset 0.36
Debt-to-Equity 0.34
Debt-to-EBITDA -0.36
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.6
Distress
Grey
Safe
Beneish M-Score -2.34
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.7
9-Day RSI 50.99
14-Day RSI 46.79
6-1 Month Momentum % -40
12-1 Month Momentum % -70.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.34
Quick Ratio 2.34
Cash Ratio 2.08
Days Sales Outstanding 35.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.1

Financials (Next Earnings Date:2023-03-01 Est.)

PIRS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PIRS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 28.499
EPS (TTM) ($) -0.47
Beta 1.15
Volatility % 49.23
14-Day RSI 46.79
14-Day ATR ($) 0.067063
20-Day SMA ($) 1.00652
12-1 Month Momentum % -70.86
52-Week Range ($) 0.9244 - 4.0755
Shares Outstanding (Mil) 74.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pieris Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Pieris Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.